电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Melanoma Antigen Family B, 3 (MAGEB3) (N-Term) Peptide

MAGEB3 适用: 人 宿主: 合成 BP, WB
产品编号 ABIN979736
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Melanoma Antigen Family B, 3 (MAGEB3) (N-Term) Peptide (ABIN979736)

抗原

MAGEB3 (Melanoma Antigen Family B, 3 (MAGEB3))

宿主

资源

  • 3
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB)
  • 蛋白结构域

    N-Term

    产品特性

    This is a synthetic peptide designed for use in combination with anti-MAGEB3 antibody (Catalog #: ARP56338_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    纯化方法

    Purified
  • 应用备注

    Each Investigator should determine their own optimal working dilution for specific applications.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    浓度

    1 mg/mL

    缓冲液

    Final peptide concentration is 1 mg/mL in PBS.

    注意事项

    Avoid repeated freeze-thaw cycles.

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • 抗原

    MAGEB3 (Melanoma Antigen Family B, 3 (MAGEB3))

    背景

    This gene is a MAGE-B subfamily member of the MAGE gene family. MAGE family member proteins direct the expression of tumor antigens recognized on a human melanoma by autologous cytolytic T lymphocytes. There are two known clusters of MAGE genes on chromos

    Alias Symbols: CT3.5

    Protein Size: 346

    分子量

    39 kDa

    基因ID

    4114

    NCBI登录号

    NM_002365, NP_002356

    UniProt

    O15480
You are here: